Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression

Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression have?

Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression has 192 citations in the OpenAlex counts ScholarIQ stores.

When was Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression published?

Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression has 1993 year in the ScholarIQ index.

What is the open-access status of Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression?

Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression has closed oa status in the ScholarIQ index.

What is the DOI of Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression?

The DOI for Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression is on the source record.

What is the PMID of Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression?

The PMID for Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression is on the source record.

What is the OpenAlex record for Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression?

The OpenAlex for Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression is on the source record.